D.E. Shaw & Co
OMCL icon

D.E. Shaw & Co’s Omnicell OMCL Stock Holding History

D.E. Shaw & Co’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$1.48M – 5621
2021
Q3 		$1.48M Hold
10,000
– – ﹤0.01% 3283
2021
Q2 		$1.51M Buy
+10,000
New +$1.39M ﹤0.01% 3204

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

D.E. Shaw & Co's OMCL Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Omnicell (OMCL) stake by 46% in Q2 2026, selling an estimated $9.96M and leaving 287,461 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #1682.

D.E. Shaw & Co first reported a position in OMCL in Q4 2014 and has held it in 38 quarters since. The position peaked at $48.8M in Q1 2025. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • D.E. Shaw & Co held 287,461 shares of Omnicell worth $11.9M as of Q2 2026.
  • D.E. Shaw & Co sold 247,150 Omnicell shares in Q2 2026, an estimated $9.96M.
  • Omnicell made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1682 holding.
  • D.E. Shaw & Co first reported a position in Omnicell in Q4 2014 and has held it in 38 quarters since.
  • D.E. Shaw & Co's Omnicell position peaked at $48.8M in Q1 2025.
  • 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.